Overview

The Effects of Thalidomide on Symptom Clusters

Status:
Completed

Trial end date:
2013-01-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if thalidomide can improve symptoms such as pain, fatigue,anxiety, poor appetite, depression, and sleep problems in patients with advanced cancer.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Celgene Corporation

Treatments:

Thalidomide